Paulyn Harris
Family · Rancho Cucamonga, CANPI 1154801140
Payments from drug & device makers
Across 74 payments — averaging $22.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$322
- Lilly USA, LLC$316
- Novo Nordisk$209
- AstraZeneca$130
- Dexcom, Inc.$125
- Bayer$80
- plus $513 from 16 others
What the payments were for
- Food & beverage$1,696100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 16 | $322 |
| Lilly USA, LLC | 15 | $316 |
| Novo Nordisk | 6 | $209 |
| AstraZeneca | 6 | $130 |
| Dexcom, Inc. | 5 | $125 |
| Bayer | 4 | $80 |
| Astellas Pharma US Inc | 2 | $53 |
| Novartis | 2 | $45 |
| Boehringer Ingelheim | 2 | $44 |
| Merck | 2 | $43 |
| Exact Sciences | 2 | $42 |
| Acadia Pharmaceuticals Inc | 1 | $40 |
| Shield Therapeutics Inc | 1 | $35 |
| Cardinal Health 414 LLC | 1 | $34 |
| AbbVie | 1 | $26 |
| Cequr Corporation | 2 | $26 |
| Radius Health, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| GSK | 1 | $21 |
| Akebia Therapeutics Inc | 1 | $21 |
| Fresenius USA Marketing, Inc. | 1 | $21 |
| Ardelyx, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Saxenda$116
How this compares
$1,696 in reported general payments places this provider in the 80th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 37 | $32,117 |
| TrulicityDulaglutide | 30 | $31,104 |
| Diclofenac Sodium | 14 | $29,496 |
| OzempicSemaglutide | 24 | $29,281 |
| JanuviaSitagliptin Phosphate | 15 | $19,088 |
| ProliaDenosumab | 11 | $18,596 |
| FarxigaDapagliflozin Propanediol | 12 | $9,605 |
| EliquisApixaban | 11 | $7,607 |
| JentaduetoLinagliptin/Metformin Hcl | 12 | $5,805 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $5,653 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 33 | $2,795 |
| Atorvastatin Calcium | 217 | $2,516 |
| Novolog FlexpenInsulin Aspart | 11 | $1,965 |
| Losartan Potassium | 132 | $1,755 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 19 | $1,430 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Jentadueto | $44 | $37,92249 claims |
| Lilly USA, LLCTrulicity | $316 | $31,10430 claims |
| Novo NordiskOzempic | $209 | $29,28124 claims |
| MerckJanuvia | $43 | $19,08815 claims |
| AmgenProlia | $322 | $18,59611 claims |
| AstraZenecaFarxiga | $130 | $9,60512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,634 family providers in California.
Other family in Rancho Cucamonga
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.